Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pavmed Inc Series Z WT (PAVMZ)

Pavmed Inc Series Z WT (PAVMZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 2,452 K
  • Annual Income, $ -64,175 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PAVMZ with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0151 +39.07%
on 05/01/24
0.0499 -57.92%
on 05/01/24
-0.0189 (-47.37%)
since 04/03/24
3-Month
0.0151 +39.07%
on 05/01/24
0.0678 -69.03%
on 02/09/24
-0.0410 (-66.13%)
since 02/02/24
52-Week
0.0012 +1,650.00%
on 06/16/23
0.2720 -92.28%
on 09/11/23
-0.1252 (-85.64%)
since 05/03/23

Most Recent Stories

More News
PAVmed and Lucid Diagnostics Provide Strategic Business Update

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned...

PAVM : 2.07 (-7.59%)
PAVMZ : 0.0210 (-55.88%)
LUCD : 0.9297 (-2.14%)
PAVmed and Lucid Diagnostics to Provide Strategic Business Update

PAVmed Inc. (Nasdaq: PAVM, PAVMZ), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned subsidiaries...

PAVM : 2.07 (-7.59%)
PAVMZ : 0.0210 (-55.88%)
LUCD : 0.9297 (-2.14%)
PAVmed Partners with Novosound on Ultrasound Imaging Technology

PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (“PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced...

PAVM : 2.07 (-7.59%)
PAVMZ : 0.0210 (-55.88%)
LUCD : 0.9297 (-2.14%)
PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform

PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (“PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced...

PAVM : 2.07 (-7.59%)
PAVMZ : 0.0210 (-55.88%)
LUCD : 0.9297 (-2.14%)
Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq:...

PAVMZ : 0.0210 (-55.88%)
LUCD : 0.9297 (-2.14%)
PAVM : 2.07 (-7.59%)
Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”),...

PAVMZ : 0.0210 (-55.88%)
LUCD : 0.9297 (-2.14%)
PAVM : 2.07 (-7.59%)
Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM,...

PAVMZ : 0.0210 (-55.88%)
LUCD : 0.9297 (-2.14%)
PAVM : 2.07 (-7.59%)
PAVmed to Participate in BTIG Digital Health Forum

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”, the “Company”), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors,...

PAVM : 2.07 (-7.59%)
PAVMZ : 0.0210 (-55.88%)
LUCD : 0.9297 (-2.14%)
Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”, the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM,...

PAVMZ : 0.0210 (-55.88%)
LUCD : 0.9297 (-2.14%)
PAVM : 2.07 (-7.59%)
Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”, the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM,...

PAVMZ : 0.0210 (-55.88%)
LUCD : 0.9297 (-2.14%)
PAVM : 2.07 (-7.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar